Cargando…

Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population

Background: The identification of genetic risk factors for Acute Lymphoblastic Leukemia (ALL), are increasingly urgent and necessary. Objective: The purpose of this study is to determine the association of the genetic polymorphisms ABCC1 rs3743527, NCF4 rs1883112 and CBR3 rs1056892 with ALL. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Gándara-Mireles, Jesús Alonso, Lares-Asseff, Ismael, Reyes Espinoza, Elio Aarón, Blanco, Javier G., Chairez Hernández, Isaias, Córdova Hurtado, Lourdes Patricia, Loera Castañeda, Verónica, Patrón Romero, Leslie, Venzor Sánchez, Cristina, Payan Gándara, Hugo, Arechiga Gurrola, Dinora, Almanza Reyes, Horacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887511/
https://www.ncbi.nlm.nih.gov/pubmed/33613283
http://dx.doi.org/10.3389/fphar.2020.616630
_version_ 1783651999713067008
author Gándara-Mireles, Jesús Alonso
Lares-Asseff, Ismael
Reyes Espinoza, Elio Aarón
Blanco, Javier G.
Chairez Hernández, Isaias
Córdova Hurtado, Lourdes Patricia
Loera Castañeda, Verónica
Patrón Romero, Leslie
Venzor Sánchez, Cristina
Payan Gándara, Hugo
Arechiga Gurrola, Dinora
Almanza Reyes, Horacio
author_facet Gándara-Mireles, Jesús Alonso
Lares-Asseff, Ismael
Reyes Espinoza, Elio Aarón
Blanco, Javier G.
Chairez Hernández, Isaias
Córdova Hurtado, Lourdes Patricia
Loera Castañeda, Verónica
Patrón Romero, Leslie
Venzor Sánchez, Cristina
Payan Gándara, Hugo
Arechiga Gurrola, Dinora
Almanza Reyes, Horacio
author_sort Gándara-Mireles, Jesús Alonso
collection PubMed
description Background: The identification of genetic risk factors for Acute Lymphoblastic Leukemia (ALL), are increasingly urgent and necessary. Objective: The purpose of this study is to determine the association of the genetic polymorphisms ABCC1 rs3743527, NCF4 rs1883112 and CBR3 rs1056892 with ALL. Methods: DNA samples were obtained in 71 children with ALL (from 2 to 18 years) and in 71 controls without ALL, to determine the polymorphisms by real-time polymerase chain reaction (qPCR), using specific TaqMan probes in a StepOne(®) thermal cycler (Applied Biosystems, United States). Results: The results of the Odds Ratio analysis show that in the rs1883112 polymorphism of the NCF4 gene, the heterozygous allele has a risk effect for ALL (OR = 3.1870, CI = 1.8880–7.9383 and p = 0.0002), in turn the mutated genotype (AA) is associated with a protective effect (OR = 0.26, 0.1248 to 0.5434 and p = 0.0003). On the other hand, the CBR3 rs1056892 polymorphism shows a significant association of risk to ALL, in the presence of the HT genotype (OR = 2.77, IC = 1.3837 to 5.5651 and p = 0.004) and the mutated genotype of this polymorphism has a significant association with protection to ALL in the HM genotype (OR = 0.52, IC = 0.2639 to 1.0304 and p = 0.05). While the inheritance models of the polymorphisms let us see that of the rs1883112 polymorphism of the NCF4 polymorphism; the HT genotype of the codominant model shows a protective effect against ALL (OR = 0.4117, IC = 0.1718 to 0.9866 and p = 0.04), the recessive model shows us and confirms what we already saw in table number 3, being that there is an association with protective effect in the HM genotype (OR = 0.2604, IC = 0.1248 to 0.5434 and p = 0.0003). In the polymorphism rs1056892 of the CBR3 gene, a protection association was found in the heterozygous allele of the codominant model (OR = 0.3448, IC = 0.1375 to 0.8896 and p = 0.0274). In addition, the recessive inheritance model for the HM genotype shows a protective effect to ALL, (OR = 0.52, CI = 0.9919 to 3.8638 and p = 0.05). Conclusion: There is an evident impact of the NCF4 rs1883112 and CBR3 rs1056892 polymorphisms with an increased risk of susceptibility to ALL; Likewise, through the codominant inheritance model, the effect of the variation of the CBR3 rs1056892 gene as a protective factor against ALL was evaluated.
format Online
Article
Text
id pubmed-7887511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78875112021-02-18 Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population Gándara-Mireles, Jesús Alonso Lares-Asseff, Ismael Reyes Espinoza, Elio Aarón Blanco, Javier G. Chairez Hernández, Isaias Córdova Hurtado, Lourdes Patricia Loera Castañeda, Verónica Patrón Romero, Leslie Venzor Sánchez, Cristina Payan Gándara, Hugo Arechiga Gurrola, Dinora Almanza Reyes, Horacio Front Pharmacol Pharmacology Background: The identification of genetic risk factors for Acute Lymphoblastic Leukemia (ALL), are increasingly urgent and necessary. Objective: The purpose of this study is to determine the association of the genetic polymorphisms ABCC1 rs3743527, NCF4 rs1883112 and CBR3 rs1056892 with ALL. Methods: DNA samples were obtained in 71 children with ALL (from 2 to 18 years) and in 71 controls without ALL, to determine the polymorphisms by real-time polymerase chain reaction (qPCR), using specific TaqMan probes in a StepOne(®) thermal cycler (Applied Biosystems, United States). Results: The results of the Odds Ratio analysis show that in the rs1883112 polymorphism of the NCF4 gene, the heterozygous allele has a risk effect for ALL (OR = 3.1870, CI = 1.8880–7.9383 and p = 0.0002), in turn the mutated genotype (AA) is associated with a protective effect (OR = 0.26, 0.1248 to 0.5434 and p = 0.0003). On the other hand, the CBR3 rs1056892 polymorphism shows a significant association of risk to ALL, in the presence of the HT genotype (OR = 2.77, IC = 1.3837 to 5.5651 and p = 0.004) and the mutated genotype of this polymorphism has a significant association with protection to ALL in the HM genotype (OR = 0.52, IC = 0.2639 to 1.0304 and p = 0.05). While the inheritance models of the polymorphisms let us see that of the rs1883112 polymorphism of the NCF4 polymorphism; the HT genotype of the codominant model shows a protective effect against ALL (OR = 0.4117, IC = 0.1718 to 0.9866 and p = 0.04), the recessive model shows us and confirms what we already saw in table number 3, being that there is an association with protective effect in the HM genotype (OR = 0.2604, IC = 0.1248 to 0.5434 and p = 0.0003). In the polymorphism rs1056892 of the CBR3 gene, a protection association was found in the heterozygous allele of the codominant model (OR = 0.3448, IC = 0.1375 to 0.8896 and p = 0.0274). In addition, the recessive inheritance model for the HM genotype shows a protective effect to ALL, (OR = 0.52, CI = 0.9919 to 3.8638 and p = 0.05). Conclusion: There is an evident impact of the NCF4 rs1883112 and CBR3 rs1056892 polymorphisms with an increased risk of susceptibility to ALL; Likewise, through the codominant inheritance model, the effect of the variation of the CBR3 rs1056892 gene as a protective factor against ALL was evaluated. Frontiers Media S.A. 2021-02-02 /pmc/articles/PMC7887511/ /pubmed/33613283 http://dx.doi.org/10.3389/fphar.2020.616630 Text en Copyright © 2021 Gándara-Mireles, Lares-Asseff, Reyes Espinoza, Blanco, Chairez Hernández, Córdova Hurtado, Loera Castañeda, Patrón Romero, Venzor Sánchez, Payan Gándara, Arechiga Gurrola and Almanza Reyes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gándara-Mireles, Jesús Alonso
Lares-Asseff, Ismael
Reyes Espinoza, Elio Aarón
Blanco, Javier G.
Chairez Hernández, Isaias
Córdova Hurtado, Lourdes Patricia
Loera Castañeda, Verónica
Patrón Romero, Leslie
Venzor Sánchez, Cristina
Payan Gándara, Hugo
Arechiga Gurrola, Dinora
Almanza Reyes, Horacio
Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
title Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
title_full Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
title_fullStr Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
title_full_unstemmed Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
title_short Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
title_sort genotype analysis of abcc1, ncf4 and cbr3 polymorphism and the association with childhood acute lymphoblastic leukemia in mexican childhood population
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887511/
https://www.ncbi.nlm.nih.gov/pubmed/33613283
http://dx.doi.org/10.3389/fphar.2020.616630
work_keys_str_mv AT gandaramirelesjesusalonso genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT laresasseffismael genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT reyesespinozaelioaaron genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT blancojavierg genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT chairezhernandezisaias genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT cordovahurtadolourdespatricia genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT loeracastanedaveronica genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT patronromeroleslie genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT venzorsanchezcristina genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT payangandarahugo genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT arechigagurroladinora genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation
AT almanzareyeshoracio genotypeanalysisofabcc1ncf4andcbr3polymorphismandtheassociationwithchildhoodacutelymphoblasticleukemiainmexicanchildhoodpopulation